Does BENRALIZUMAB Cause Inappropriate schedule of product administration? 456 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 456 reports of Inappropriate schedule of product administration have been filed in association with BENRALIZUMAB (FASENRA). This represents 2.9% of all adverse event reports for BENRALIZUMAB.
456
Reports of Inappropriate schedule of product administration with BENRALIZUMAB
2.9%
of all BENRALIZUMAB reports
9
Deaths
141
Hospitalizations
How Dangerous Is Inappropriate schedule of product administration From BENRALIZUMAB?
Of the 456 reports, 9 (2.0%) resulted in death, 141 (30.9%) required hospitalization, and 13 (2.9%) were considered life-threatening.
Is Inappropriate schedule of product administration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 456 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Product dose omission issue (713)
Pneumonia (710)
Wheezing (619)
Malaise (514)
What Other Drugs Cause Inappropriate schedule of product administration?
ADAPALENE (16,473)
DUPILUMAB (14,927)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (12,546)
INSULIN GLARGINE (8,982)
INFLIXIMAB (6,847)
INFLIXIMAB-DYYB (5,977)
SECUKINUMAB (4,817)
DULAGLUTIDE (3,606)
VEDOLIZUMAB (3,259)
SACUBITRIL\VALSARTAN (2,870)
Which BENRALIZUMAB Alternatives Have Lower Inappropriate schedule of product administration Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE